Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Significant Drop in Short Interest

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 27,548,732 shares, a drop of 49.2% from the July 15th total of 54,218,169 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days. Approximately 0.1% of the shares of the company are short sold.

Sino Biopharmaceutical Price Performance

Shares of OTCMKTS:SBMFF traded up $0.04 during midday trading on Monday, reaching $0.65. The company had a trading volume of 1,000 shares, compared to its average volume of 1,861. The company’s 50 day moving average price is $0.62 and its 200 day moving average price is $0.72. Sino Biopharmaceutical has a 52-week low of $0.59 and a 52-week high of $1.24.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.